MedPath

A Pharmacokinetic Study of TS-071 in Type 2 Diabetes Mellitus Patients With Renal Dysfunctio

Phase 2
Conditions
Type 2 diabetes mellitus with renal dysfunction
Registration Number
JPRN-jRCT2080221237
Lead Sponsor
Taisho Pharmaceutical co., LTD
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Sex
All
Target Recruitment
50
Inclusion Criteria

Japanese
- Type 2 diabetes mellitus patient

etc.

Exclusion Criteria

- Non-type 2 diabetes mellitus
- Having critical heart disease, other ciruculatory disease, cerebrovascular disorder, pancreatic disease and hematologic disease

etc.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath